135 related articles for article (PubMed ID: 15368518)
21. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
22. A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo.
Haque T; Johannessen I; Dombagoda D; Sengupta C; Burns DM; Bird P; Hale G; Mieli-Vergani G; Crawford DH
J Infect Dis; 2006 Sep; 194(5):584-7. PubMed ID: 16897655
[TBL] [Abstract][Full Text] [Related]
23. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus and multiple sclerosis.
Pohl D
J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
[TBL] [Abstract][Full Text] [Related]
25. [Influence of selenium-rich rice on transformation of umbilical blood B lymphocytes by Epstein-Barr virus and Epstein-Barr virus early antigen expression].
Jian SW; Mei CE; Liang YN; Li D; Chen QL; Luo HL; Li YQ; Cai TY
Ai Zheng; 2003 Jan; 22(1):26-9. PubMed ID: 12561431
[TBL] [Abstract][Full Text] [Related]
26. Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer.
Glaser R; Padgett DA; Litsky ML; Baiocchi RA; Yang EV; Chen M; Yeh PE; Klimas NG; Marshall GD; Whiteside T; Herberman R; Kiecolt-Glaser J; Williams MV
Brain Behav Immun; 2005 Mar; 19(2):91-103. PubMed ID: 15664781
[TBL] [Abstract][Full Text] [Related]
27. The human T cell immune response to Epstein-Barr virus.
Landais E; Saulquin X; Houssaint E
Int J Dev Biol; 2005; 49(2-3):285-92. PubMed ID: 15906243
[TBL] [Abstract][Full Text] [Related]
28. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
29. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
30. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.
Seto E; Ooka T; Middeldorp J; Takada K
Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477
[TBL] [Abstract][Full Text] [Related]
31. The immune response to primary EBV infection: a role for natural killer cells.
Williams H; McAulay K; Macsween KF; Gallacher NJ; Higgins CD; Harrison N; Swerdlow AJ; Crawford DH
Br J Haematol; 2005 Apr; 129(2):266-74. PubMed ID: 15813855
[TBL] [Abstract][Full Text] [Related]
32. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
34. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
35. EBV-Specific Immune Response: Early Research and Personal Reminiscences.
Moss DJ; Lutzky VP
Curr Top Microbiol Immunol; 2015; 390(Pt 1):23-42. PubMed ID: 26424642
[TBL] [Abstract][Full Text] [Related]
36. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage.
Lan K; Verma SC; Murakami M; Bajaj B; Robertson ES
Curr Protoc Microbiol; 2007 Aug; Chapter 14():Unit 14E.2. PubMed ID: 18770612
[TBL] [Abstract][Full Text] [Related]
38. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
39. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
